Login
$BFNH
$6.10 +$0.23 (3.92%) Close

Insider Transactions

What BioForce Nanosciences Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 1
Total trades 2 6

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

Common stock only — 6 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Kaiser Richard Kaiser CEO & CFO Aug 31 Grant / award · A +316,909 $0.55 +$174K 1,234,447
Kaiser Richard Kaiser CEO & CFO Aug 20 Other Transaction · J −38,462 $0.65 −$25K 917,538
Ferguson Merle Director Apr 22 Open-market sale · S −26,700,000 $0.02 −$401K 0
Kaiser Richard Kaiser CEO & CFO Apr 20 Gift · G −4,132,000 $0.00 −$4.13K 956,000
Ferguson Merle Director Apr 20 Gift · G +4,132,000 $0.00 +$4.13K 26,700,000
Ferguson Merle Director Apr 20 Gift · G +20,580,000 $0.01 +$144K 22,568,000
Ferguson Merle CEO Oct 18 Gift · G +1,400,000 — — 17,870,000
Ferguson Merle CEO Oct 17 Gift · G +1,470,000 — — 16,470,000
Ferguson Merle CEO Oct 17 Gift · G −1,470,000 — — 15,000,000
Ferguson Merle CEO May 12 Gift · G −500,000 — — 16,470,000
Ferguson Merle CEO Dec 13 Gift · G −20,000 — — 16,970,000
Ferguson Merle CEO Sep 30 Gift · G −10,000 — — 16,990,000
Ferguson Merle CEO Dec 04 Grant / award · A +11,000,000 $0.00 +$11K 15,000,000
Cowle Ed 10% owner Dec 14 Open-market sale · S −1,146,626 $0.01 −$11.5K 425,403

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support